Matching Items (3)
Filtering by
- All Subjects: Capsaicin
- All Subjects: Breast Cancer
- Creators: Cahill, Thomas
Description
Colchicine is a chemical known for inhibiting mitosis during eukaryotic cellular reproduction by halting the tubulin formation necessary for the division of the chromosomes. The meristem is the primary source of mitosis in developing flowering plants, and it was the focus of our research to determine if the hindrance of mitosis would interfere with the production of capsaicinoids within pungent pepper plants. Moruga Scorpion peppers have one of the world's highest concentration of capsaicinoids with Scoville Heat Units (SHU) averaging 1.2 million SHU (Bannister, 2012). The highest concentration of these capsaicinoids are within the placental and endocarp regions of the fruit, which are the primary location for capsaicinoid biosynthesis (Aza-Gonzalez & Nunez-Palenius, 2010). Hindering mitosis from the earliest stage of development could lead to phenotypic abnormalities within those placental and endocarp regions, quite possibly through the mechanism of the induced polyploidy. In many cases, this polymerization interference is beneficial in cultivating plants with characterized polyploidy due to its desired increased size of fruits and leaves. Due to the lethal nature of colchicine, there is threshold of effectiveness where it may induce polyploidy or it may result in fatality. This first stage of this research sought to determine which lethal dose was required to elicit a polyploid response or lead to seed unviability. The second stage was analyzing capsaicin concentration within the fruit of the mature dosed plants to determine whether there was an effect on the capsaicinoids, and whether polyploidy played a role in those effects. The final inspection of this research was in germinating the seeds from the hottest F1 pepper that had developed the fruit the slowest of all the doses, and determining whether there were any effects on the germination or seedling development.
ContributorsKeppler, Lydia Jacqueline (Author) / Cahill, Thomas (Thesis director) / Sweat, Ken G. (Committee member) / Hackney Price, Jennifer (Committee member) / School of Mathematical and Natural Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2016-12
Description
Capsaicin and dihydrocapsaicin account for 90% of capsaicinoids when it comes to the pungency of peppers. Capsaicin stability was investigated through a cooking and storage parameter where three different tests were done; cooking duration, cooking temperature, and storage stability. The concentration of capsaicinoids was quantified through gas chromatography-mass spectrometry where those values were then used to determine the total Scoville heat units (SHU). Furthermore, half-life was determined by finding the decay rate during cooking and storage. Results showed that there was an increase in degradation of capsaicinoids concentration when peppers were cooked for a long period of time. Degradation rate increases with increasing temperatures as would be expected by the Arrhenius equation. Hence, if a maximum pungency is wanted, it is best to cook the least time as possible or add the peppers towards the end of the culinary technique. This would help by cooking the peppers for a short period of time while not being exposed to the high temperature long enough before significant degradation occurs. Lastly, the storage stability results interpreted that a maximum potency of the peppers can be retained in a freezer or refrigerator opposed to an open room temperature environment or exposure from the sun. Furthermore, the stability of peppers has a long shelf life with even that the worse storage condition's half-life value was 113.5 months (9.5 years). Thus, peppers do not need to be bought frequently because its potency will last for several years.
ContributorsBustamante, Krista Gisselle (Author) / Cahill, Thomas (Thesis director) / Sweat, Ken (Committee member) / Armendariz Guajardo, Jose (Committee member) / School of Mathematical and Natural Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2017-12
Description
Bexarotene (Bex) is a FDA-approved drug used to treat cutaneous T-cell lymphoma (CTCL). It binds with high affinity to the retinoid-X-receptor (RXR), a nuclear receptor implicated in numerous biological pathways. Bex may have the potential to attenuate estrogenic activity by acting as an estrogen receptor alpha (ERα) signaling antagonist, and can therefore be used to treat ERα-positive cancers, such as breast cancer. Using dual luciferase reporter assays, real-time qRT-PCR, and metabolic proliferation assays, the anti-estrogenic properties of Bex were ascertained. However, since Bex produces numerous contraindications, select novel RXR drug analogs were also evaluated. Results revealed that, in luciferase assays, Bex could significantly (P < 0.01) inhibit the transcriptional activity of ERα, so much so that it rivaled ER pan-antagonist ZK164015 in potency. Bex was also able to suppress the proliferation of two breast cancer cell models, MCF-7 and T-47D, and downregulate the expression of an estrogen receptor target gene (A-myb), which is responsible for cell proliferation. In addition, novel analogs A30, A33, A35, and A38 were evaluated as being more potent at inhibiting ERE-mediated transcription than Bex at lower concentrations. Analogs A34 and A35 were able to suppress MCF-7 cell proliferation to a degree comparable to that of Bex. Inhibition of T-47D cell proliferation, by contrast, was best achieved by analogs A34 and A36. For those with ERα – positive breast cancer who are refractory to current chemotherapeutics used to treat breast cancer, Bex and its analogs may prove to be useful alternative options.
ContributorsBains, Supreet (Author) / Jurutka, Peter (Thesis director) / Hackney Price, Jennifer (Committee member) / School of Life Sciences (Contributor) / Barrett, The Honors College (Contributor)
Created2016-12